Initiated Studies
Investigator
According
Conducting
Initiated
to FDA
Studies
Investigator
Regulations
According
Initiated
andto GCP
FDA
Studies
Study
Regulations
According
Guide and
2026_2027.pdf
to GCP
FDA Study
Regulations
Guide and
2026_2027.pdf
GCP Study Guide 2026_2027.pdf
Conducting Investigator Initiated
Studies According to FDA Regulations
and GCP Study Guide 2026/2027
Guidehttps://www.stuvia.com/dashboard!@_)#*)(@$)($@*($@)($@*_
Conducting InvestigatorConducting
Initiated Studies
Investigator
According
Conducting
Initiated
to FDA
Studies
Investigator
Regulations
According
Initiated
andto GCP
FDA
Studies
Study
Regulations
According
Guide and
2026_2027.pdf
to GCP
FDA Study
Regulations
Guide and
2026_2027.pdf
GCP Study Guide 2026_2027.pdf
, Conducting Investigator-Initiated Studies According to FDA Regulations and GCP.pdf Conducting Investigator-Initiated Studies According to FDA Regulations and GCP.pdf Conducting Investigator-Initiated Studies According to FDA Regulations and GCP.pdf
Terms in this set (6)
Drug Supplier/Manufacturer In addition to producing the drug the company also provides the investigator
with the drug for use in the study
Sponsor The entity who takes responsibility for the initiates a clinical investigation the
sponsor can be any legal entity including a company, an academic
organization, or an individual
Sponsor-Investigator An individual who both initiates and actually conducts, alone or with others, a
clinical investigation, i.e., under whose immediate direction the test article is
administered or dispensed to, or used involving, a subject. The term does not
include any other person other than an individual, e.g. corporation or agency.
(21 CFR, sec. 50.3)
Which of the following is an acceptable criterion for The study is not intended to be reported to FTA to support a new indication or
determining that a study of an approved drug does not support a legal and change
require an IND?
Conducting Investigator-Initiated Studies According to FDA Regulations and GCP.pdf Conducting Investigator-Initiated Studies According to FDA Regulations and GCP.pdf Conducting Investigator-Initiated Studies According to FDA Regulations and GCP.pdf